Although IHC may be less sensitive to detect EpCAM expression compared to immunomagnetic capture with ferrofluids and the CellSearch enhanced aggregation technique, our data emphasize the limitations of EpCAM-based detection of circulating tumor cells in HCC for mutational analysis due to the low frequency of CTCs in our patient cohort. This evidence concerns the gene EPCAM and neoplasm.